InvestorsHub Logo
Followers 6
Posts 957
Boards Moderated 0
Alias Born 01/04/2017

Re: None

Friday, 04/24/2020 11:32:10 PM

Friday, April 24, 2020 11:32:10 PM

Post# of 34868
Take notice to the last paragraph describing the company which appears above this section...


In discussions with Aeras Global TB Vaccine Foundation, we identified the potential of TAP for use in the joint development of their next-generation TB vaccine, said Denis Corin, TapImmune's president and CFO. But you could also look at influenza, SARS, HIV, H1N1 and many other societal pathogens. We're also working with Dr Poland and the Mayo Clinic on a new small pox vaccine. But, small pox is the tip of the iceberg. There are a number of nasty viruses that are potential bioterrorism threats and governments around the world could stockpile our TAP vaccine and call on it in the event of a bioterrorist threat.


Well, where is MRKR on this?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News